Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells.
about
Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1AlphaCoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer.The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein.Hypoxia and lineage specification of cell line-derived colorectal cancer stem cellsExpression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cellsThe correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy.Marginal effects of glucose, insulin and insulin-like growth factor on chemotherapy response in endothelial and colorectal cancer cells.Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs.Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2.HIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosis.Hypoxic human cancer cells are sensitized to BH-3 mimetic–induced apoptosis via downregulation of the Bcl-2 protein Mcl-1.STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line.Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients.Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer
P2860
Q28533909-45E1B1F8-4539-4505-A151-9062ABA927E4Q33763237-EBB24883-FB69-4A10-86FB-282B48B4F4A9Q34123758-2AE9063D-1047-484B-AC8B-72EC31875710Q34693614-A98D2E0F-B328-4C40-967F-E03CB08DF7B3Q35223337-30BA28B3-2247-4A4A-9419-ECE82C2CDAFCQ36216405-A97B9E64-EE81-4485-BD35-BC67E94E1EC0Q36785251-C74ECE06-7721-4986-908D-924CB5860EEAQ37437967-949C5E7D-8D35-4E48-80DA-9254F3857613Q38862089-556C2ACB-3CEA-4CE2-B295-B718C11A1DB0Q38930844-6988E2B0-845B-4393-8836-CE0B16532A5EQ39324644-5F030F2D-323A-42EF-B238-7D63E4979F9CQ39577806-46646A66-D410-41F7-8633-A8B543DE547CQ43499055-2760B9F2-5A46-41B4-B5BF-12EDBEF648FDQ44039441-D260651F-379B-4A38-8831-35B1C2E60643Q57416431-39007425-A78F-4211-B458-034AD8B51076
P2860
Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Contribution of HIF-1 and drug ...... poxic colorectal cancer cells.
@ast
Contribution of HIF-1 and drug ...... poxic colorectal cancer cells.
@en
type
label
Contribution of HIF-1 and drug ...... poxic colorectal cancer cells.
@ast
Contribution of HIF-1 and drug ...... poxic colorectal cancer cells.
@en
prefLabel
Contribution of HIF-1 and drug ...... poxic colorectal cancer cells.
@ast
Contribution of HIF-1 and drug ...... poxic colorectal cancer cells.
@en
P2093
P2860
P50
P356
P1476
Contribution of HIF-1 and drug ...... ypoxic colorectal cancer cells
@en
P2093
A J Eustace
C J Ottley
D G Pearson
K J Williams
M Barathova
S Brittain-Dissont
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605311
P407
P577
2009-09-15T00:00:00Z
P5875
P6179
1022432063